Back to search
FDAFDA · Food and drugs·Recall number F-0666-2021

BTREX PLUS, Dietary Supplement 2 caplets bottles, UPC 05380930802 (Physician Samples)

Published June 23, 2021 · Recall initiated: May 25, 2021

Summary

FDA records food Class III recall F-0666-2021, published June 23, 2021 and initiated May 25, 2021. Recalling firm: Lopez Gonzalez Santana Corporation; Status: Terminated; Reported quantity: 4641 units (2 tablet bottles); Lot: Lot #30637, Expiration Date 01. 2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of damaged tablets

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lopez Gonzalez Santana Corporation
Distributor
Domestic distribution only-PR
Lot
Lot #30637, Expiration Date 01. 2022
Risk classification
Class III
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was BTREX PLUS, Dietary Supplement 2 caplets bottles, UPC 05380930802 (Physician Samples) recalled?

Yes. FDA published recall F-0666-2021 on June 23, 2021. Reported hazard: CGMP Deviations: Presence of damaged tablets

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit